Study Summary:
This is a 9 week study for subjects who have been diagnosed with Bipolar I Disorder and are currently experiencing a major depressive episode. This is only for subjects who are currently taking Lithium or Depakote. Subjects will remain on Lithium or Depakote and receive double-blind, randomized, placebo-controlled study medication.
Qualified Participants Must:
• Have been previously diagnosed with Bipolar I Disorder and be on either Lithium or Depakote (or both) for at least 28 days
•
Be willing to provide authorization to obtain prior treatment records
•
Be depressed for the past 4 weeks and no longer than 12 months
•
Be between the ages of 18 and 75 years
•
Be in good general health
•
Be free of alcohol or substance abuse or dependence for at least 6 months
•
Meet other study enrollment criteria
Qualified Participants May Receive:
Free psychiatric and medical evaluation including routine laboratory testing.
, study medication and study follow-up visits free of cost, and $60.00 per completed study visit travel compensation.